Generics Analysis Key Patent Case Reviews

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Cancer Drug News 26 JANUARY 2015

Cancer Drug News 26 JANUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • January 2015
  • 20 pages

Industry Trend Analysis - CAR-T Market Gaining Traction Industry Brief - EC Favours Iclusig's Approved Indications Throughout Europe Industry Brief - Hybrigenics Launches Inecalcitol Phase II Study In CML Industry Brief - Curis/Aurigene Collaborate To Develop Immuno-Oncology/Precision Oncology Targets ...

Industries: Drug and Medication | Countries: China, World, United States, Europe

Anti-Infective Drug News 26 JANUARY 2015

Anti-Infective Drug News 26 JANUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • January 2015
  • 16 pages

Industry Trend Analysis - US HCV Drug Pricing Battle To Extend To Europe Industry Brief - Roche/Meiji/Fedora Enter Collaboration For Development Of OP0595 Industry Brief - Valneva To Acquire Dukoral Vaccine From Crucell Industry Brief - Aradigm Granted Key Composition Of Matter Patents For Pulmaquin ...

Industries: Drug and Medication | Countries: United States, Canada, India, World, United Kingdom, Europe, North America

World Generic Markets 19 JANUARY 2015

World Generic Markets 19 JANUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • January 2015
  • 20 pages

Industry Trend Analysis - Despite Overall Upward Trend, FTC Report Shows Fluctuations In Settlement Agreements Industry Brief - Abbott Completes Acquisition Of CFR Industry Brief - Mylan Launches Valsartan In US Industry Trend Analysis - US Approval Of Sandoz' Filgrastim Advances With Small Steps, Not ...

Industries: Drug and Medication | Countries: United States

CNS Drug News 19 JANUARY 2015

CNS Drug News 19 JANUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • January 2015
  • 24 pages

Industry Trend Analysis - Expanded Portfolio Will Help Biogen Idec Sustain Growth Industry Brief - Neuropore/UCB Enter Worldwide Collaboration And Agreement Industry Brief - FDA Approves AbbVie's Duopa For Motor Fluctuations In Advanced PD Patients Industry Brief - FDA Approves Rytary For PD Industry ...

Industries: Drug and Medication | Countries: Japan, United States

A Product and Pipeline Analysis of the Antibacterial Drugs Market : Regulatory Approaches to Combat Microbial Resistance and Stimulate Antibiotics R&D

A Product and Pipeline Analysis of the Antibacterial Drugs Market : Regulatory Approaches to Combat Microbial Resistance and Stimulate Antibiotics R&D

  • $ 5 000
  • Industry report
  • by Frost & Sullivan
  • January 2015
  • 122 pages

Key Findings •2014 has turned out to be a flagship year in the history of antibacterial drugs development. oThree new systemic antibacterial drugs gained Food and Drugs Administration (FDA) approval for acute bacterial skin and skin structure infection in 2014, including Dalvance (Durata Therapeutics), ...

Industries: Drug and Medication | Countries: United States, United Kingdom

Cancer Drug News 19 JANUARY 2015

Cancer Drug News 19 JANUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • January 2015
  • 16 pages

Industry Trend Analysis - Keytruda/Opdivo Competition To Intensify Industry Brief - Amgen/MD Anderson Collaborate To Develop BiTE Therapies For MDS Industry Brief - Solasia/Meiji Sign Japanese Darinaparsin Licensing Deal For PTCL Industry Brief - Cellectis/Ohio State University Team Up To Develop CAR ...

Industries: Drug and Medication | Countries: United States, Japan, United Kingdom

Cancer Drug News 12 JANUARY 2015

Cancer Drug News 12 JANUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • January 2015
  • 20 pages

Industry Trend Analysis - Incentives Will Continue To Generate Interest In Orphan Diseases Industry Trend Analysis - SABCS Highlights Focus On HER2- And PD-1-Targeting Drugs For BC Industry Brief - KHK/Syndax Sign Deal To Develop Entinostat In Japan/Korea Industry Brief - Pfizer Updates On Ibrance's ...

Industries: Drug and Medication | Countries: United States, China

Anti-Infective Drug News 12 JANUARY 2015

Anti-Infective Drug News 12 JANUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • January 2015
  • 24 pages

Industry Trend Analysis - High NME FDA Approvals In 2014 Indicates New Era For Anti-Infectives Industry Brief - Xydalba Gains CHMP Positive Opinion For ABSSSIs In Adults Industry Brief - Zevtera Gains Swissmedic Approval For Pneumonia Industry Brief - Phylogica/Genentech Enter Collaboration For Novel ...

Industries: Drug and Medication | Countries: South Africa, Canada, Africa, World, United States, United Kingdom

American Bio Medica Corporation (Symbol:ABMC) SWOT Analysis, Strategy, Revenues and Profits

American Bio Medica Corporation (Symbol:ABMC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. American Bio Medica Corporation SWOT Analysis report provides you ...

Industries: Drug and Medication | Countries: United States

Smruthi Organics Limited (Symbol:590046) SWOT Analysis, Strategy, Revenues and Profits

Smruthi Organics Limited (Symbol:590046) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Smruthi Organics Limited SWOT Analysis report provides you a strategic ...

Industries: Drug and Medication | Countries: United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.